Description Usage Arguments Author(s) References
The graphical representation of dose escalation for each patient in the trial.
1 2 |
x |
a "dose" object. |
y |
the "y" argument is not used in the plot-method for "dose" object. |
ask |
Choose plot or not; defaults to TRUE. |
CI |
Indicate if the "dose" object includes the 95% credible interval for the posterior dose response plot; defaults to TRUE. |
... |
other arguments to the |
Artemis Toumazi artemis.toumazi@gmail.com, Moreno Ursino moreno.ursino@inserm.fr, Sarah Zohar sarah.zohar@inserm.fr
Ursino, M., et al, (2017) Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations, Biometrical Journal, <doi:10.1002/bimj.201600084>.
Toumazi, A., et al, (2018) dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials, Computer Methods and Programs in Biomedicine, <doi:10.1016/j.cmpb.2018.01.023>.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.